Author Correction: Neoadjuvant immunotherapy for dMMR and pMMR colorectal cancers: therapeutic strategies and putative biomarkers of response

Affiliations

¹ Division of Oncology, Leeds Institute of Medical Research, University of Leeds, Leeds, UK. c.williams1@leeds.ac.uk.
² Department of Oncology, KU Leuven, Leuven, Belgium. ally.peddle@kuleuven.be.
³ Department of Gastrointestinal Oncology, City of Hope Orange County Lennar Foundation Cancer Center, Irvine, CA, USA.
⁴ Division of Oncology, Leeds Institute of Medical Research, University of Leeds, Leeds, UK.
⁵ School of Cancer Sciences, University of Glasgow, Glasgow, UK.
⁶ Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
⁷ Department of Oncology, KU Leuven, Leuven, Belgium.

^# Contributed equally.

Published Erratum

Christopher J M Williams et al. Nat Rev Clin Oncol. 2024 Dec.

. 2024 Dec;21(12):903.

doi: 10.1038/s41571-024-00955-2.

¹ Division of Oncology, Leeds Institute of Medical Research, University of Leeds, Leeds, UK. c.williams1@leeds.ac.uk.
² Department of Oncology, KU Leuven, Leuven, Belgium. ally.peddle@kuleuven.be.
³ Department of Gastrointestinal Oncology, City of Hope Orange County Lennar Foundation Cancer Center, Irvine, CA, USA.
⁴ Division of Oncology, Leeds Institute of Medical Research, University of Leeds, Leeds, UK.
⁵ School of Cancer Sciences, University of Glasgow, Glasgow, UK.
⁶ Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
⁷ Department of Oncology, KU Leuven, Leuven, Belgium.

^# Contributed equally.

No abstract available

Erratum for

Neoadjuvant immunotherapy for dMMR and pMMR colorectal cancers: therapeutic strategies and putative biomarkers of response.
Williams CJM, Peddle AM, Kasi PM, Seligmann JF, Roxburgh CS, Middleton GW, Tejpar S. Williams CJM, et al. Nat Rev Clin Oncol. 2024 Dec;21(12):839-851. doi: 10.1038/s41571-024-00943-6. Epub 2024 Sep 24. Nat Rev Clin Oncol. 2024. PMID: 39317818 Review.